Combat Medical raises £2.6 million Series A to advance treatment of BCG unresponsive bladder cancer

https://www.news-medical.net/news/20260312/Combat-Medical-raises-c2a326-million-Series-A-to-advance-treatment-of-BCG-unresponsive-bladder-cancer.aspx Combat Medical (Combat), a medical device company optimizing the delivery and efficacy of cancer therapeutics, today announced it has raised £2.6 million in the first close of a Series A financing to advance its hyperthermic intravesical chemotherapy treatment, HIVEC® through phase 3 clinical trials and toward FDA registration. The round was led by T&J Meyer Family Foundation, and included investment from Varia Ventures, NW Angel Fund and non-institutional family offices and individuals.